Interaction of isoflurane with the dopamine transporter

Anesthesiology

Volumn 98, Issue 2, 2003, Pages 404-411

  Votaw, John ^a   Byas Smith, Michael ^b   Hua, Jian ^b   Voll, Ronald ^b   Martarello, Laurent ^b   Levey, Allan I ^b   Bowman, F DuBois ^b   Goodman, Mark ^b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE TRANSPORTER; ISOFLURANE; N3 FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4' CHLOROPHENYL)TROPANE F 18; RADIOLIGAND; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 3 (4 CHLOROPHENYL) 8 (2 FLUOROETHYL)NORTROPANE; 2-CARBOMETHOXY-3-(4-CHLOROPHENYL)-8-(2-FLUOROETHYL)NORTROPANE; CARRIER PROTEIN; DIAGNOSTIC AGENT; INHALATION ANESTHETIC AGENT; MEMBRANE PROTEIN; NERVE PROTEIN; NORTROPANE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SLC6A3 PROTEIN, HUMAN; SLC6A3 PROTEIN, RAT;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CELL TRANSPORT; CEREBELLUM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; DOPAMINERGIC TRANSMISSION; DRUG PROTEIN BINDING; FEMALE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RHESUS MONKEY; STAINING; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; CELL LINE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; HEMODYNAMICS; HUMAN; IMMUNOBLOTTING; KIDNEY; MACACA; METABOLISM; RAT; SYNTHESIS;

ANESTHETICS, INHALATION; ANIMALS; CELL LINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEMODYNAMIC PROCESSES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; ISOFLURANE; KIDNEY; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NORTROPANES; RADIOPHARMACEUTICALS; RATS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037318137     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200302000-00021     Document Type: Article

References (34)

1. Haydon DA, Urban BW: The effects of some inhalation anaesthetics on the sodium current of the squid giant axon. J Physiol (Lond) 1983; 341:429-39
2. Richards CD, Russell WJ, Smaje JC: The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. J Physiol (Lond) 1975; 248:121-42
3. Richards CD, White AE: The actions of volatile anaesthetics on synaptic transmission in the dentate gyrus. J Physiol (Lond) 1975; 252:241-57
4. Franks NP, Lieb WR: Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367:607-14
5. Harrison NL: Ion channels take center stage: twin spotlights on two anesthetic targets (editorial comment). ANESTHESIOLOGY 2000; 92:936-8
6. Zuo Z: Isoflurane enhances glutamate uptake via glutamate transporters in rat glial cells. Neuroreport 2001; 12:1077-80
7. Schlame M, Hemmings HC Jr: Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism. ANESTHESIOLOGY 1995; 82:1406-16
8. Eckenhoff RG, Fagan D: Inhalation anaesthetic competition at high-affinity cocaine binding sites in rat brain synaptosomes. Br J Anaesth 1994; 73:820-5
9. Fink-Jensen A, Ingwersen SH, Nielsen PG, Hansen L, Nielsen EB, Hansen AJ: Halothane anesthesia enhances the effect of dopamine uptake inhibition on interstitial levels of striatal dopamine. Naunyn Schmiedebergs Arch Pharmacol 1994; 350:239-44
10. Chen NH, Reith ME: In vivo microdialysis for measurement of extracellular monoamine levels following inhibition of monoamine transporters. Methods Enzymol 1998; 296:719-30
11. Tsukada H, Harada N, Nishiyama S, Ohba H, Kakiuchi T: Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis. Brain Res 2000; 860:141-8
12. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG: Cocaine self-administration in dopamine-transporter knockout mice. [erratum appears in Nat Neurosci 1998; 1:330]. Nat Neurosci 1998; 1:132-7
13. Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, Goodman MM: Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT. Synapse 2002; 44:203-10
14. Goodman MM, Kabalka GW, Kung MP, Kung HF, Meyer MA: Synthesis of [18F]-N-3-Buoropropyl-2β -carbomethoxy-3β -(4′-chlorophenyl)tropane: A high affinity neuroligand to map dopamine uptake sites by PET. J Label Cmpd Radiopharm 1994; 34:488-90
15. Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, Votaw J, Ely TD, Lambert P, Owens MJ, Camp VM, Malveaux E, Hoffman JM: 18F-labeled FECNT: A selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol 2000; 27:1-12
16. Lammertsma AA, Cunningham VJ, Deiber MP, Heather JD, Bloomfield PM, Nutt J, Frackowiak RS, Jones T: Combination of dynamic and integral methods for generating reproducible functional CBF images. J Cereb Blood Flow Metab 1990; 10:675-86
17. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carrol FI, Howell LL: Self-administration of cocaine and the cocaine analog RTI-113: Relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 2002; 43:78-85
18. Lassen N, Perl W: Tracer Kinetic Methods in Medical Physiology. New York, Raven Press, 1979
19. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ: A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15:217-27
20. Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI: Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 1997; 41:530-9
21. Flynn DD, Ferrari-DiLeo G, Mash DC, Levey AI: Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J Neurochem 1995; 64:1888-91
22. Lee FJ, Pristupa ZB, Ciliax BJ, Levey AI, Niznik HB: The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain. J Biol Chem 1996; 271:20885-94
23. Fleiss JL: Statistical Methods for Rates and Proportions. New York, John Wiley and Sons, 1981
24. Sugimura M, Kitayama S, Morita K, Irifune M, Takarada T, Kawahara M, Dohi T: Effects of volatile and intravenous anesthetics on the uptake of GABA, glutamate and dopamine by their transporters heterologously expressed in COS cells and in rat brain synaptosomes. Toxicol Lett 2001; 123:69-76
25. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S: Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR1 2909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 1999; 849:85-96
26. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N: Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]betaCFT and [(11)C]beta-CIT-FE in the monkey brain. Synapse 2001; 42:273-80
27. Kofke WA, Stiller RL, Rose ME: Comparison of extracellular dopamine concentration in awake unstressed and postsurgical nitrous oxide sedated rats. J Neurosurg Anesthesiol 1995; 7:280-3
28. Murakawa M, Shingu K, Mori K: Effects of nitrous oxide on the brain catecholamines in rats. Ann Acad Med Singapore 1994; 23:452-5
29. Gillman MA, Sandyk R: Nitrous oxide ameliorates spasmodic torticollis. Eur Neurol 1985; 24:292-3
30. Reinstrup P, Ryding E, Algotsson L, Messeter K, Asgeirsson B, Uski T: Distribution of cerebral blood flow during anesthesia with isoflurane or halothane in humans. ANESTHESIOLOGY 1995; 82:359-66
31. Newberg LA, Milde JH, Michenfelder JD: The cerebral metabolic effects of isoflurane at and above concentrations that suppress cortical electrical activity. ANESTHESIOLOGY 1983; 59:23-8
32. Gyulai FE, Mintun MA, Firestone LL: Dose-dependent enhancement of in vivo GABA(A)-benzodiazepine receptor binding by isoflurane. ANESTHESIOLOGY 2001; 95:585-93
33. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C: Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 1998; 71:1289-97
34. Saunders C. Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A: Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A 2000; 97:6850-5